Indo Us Bio Tech Ltd vs Shanti Overseas India Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Sep 26, 2026

Key Highlights

The Latest Trading Price of Indo US Bio-Tech Ltd is ₹ 80.5 as of 25 Sep 15:30 . The P/E Ratio of Indo US Bio-Tech Ltd changed from 4 on March 2021 to 0 on March 2026 . This represents a CAGR of -100.00% over 6 yearsThe P/E Ratio of Shanti Overseas (India) Ltd changed from 335.7 on March 2021 to 0 on March 2026 . This represents a CAGR of -100.00% over 6 years The Market Cap of Indo US Bio-Tech Ltd changed from ₹ 19.75 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of -100.00% over 6 yearsThe Market Cap of Shanti Overseas (India) Ltd changed from ₹ 26.1 crore on March 2021 to ₹ 5.72 crore on March 2026 . This represents a CAGR of -22.35% over 6 years The revenue of Indo US Bio-Tech Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Shanti Overseas (India) Ltd for the Jun '26 is ₹ 0.27 crore as compare to the Mar '26 revenue of ₹ 5.39 crore. This represent the decline of -94.99% The ebitda of Indo US Bio-Tech Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Shanti Overseas (India) Ltd for the Jun '26 is ₹ 0.26 crore as compare to the Mar '26 ebitda of ₹ -4.48 crore. This represent the decline of -105% The net profit of Indo US Bio-Tech Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% The net profit of Shanti Overseas (India) Ltd changed from ₹ -0.49 crore to ₹ 0.03 crore over 9 quarters. This represents a CAGR of NaN% The Dividend Payout of Indo US Bio-Tech Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Shanti Overseas (India) Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Indo US Bio-Tech Ltd

Indo Us Bio-Tech Limited was originally incorporated as 'Pollucid Bio-Tech Private Limited' at Junagadh on February 4, 2004.
Subsequently, the name was change to 'Pellucid Bio-Tech Private Limited' on January 5, 2005.
Later on, the name of the Company was changed to 'Indo Us Bio-Tech Private Limited' on March 9, 2007.
Consequently, upon conversion into Public Limited Company, the name of the Company was changed to 'Indo Us Bio-Tech Limited' on January 11, 2018. The Company is an ISO 9001-2008 company, involved in crop research & development throw breeding, production of seeds, processing, packing and marketing of high performing hybrid and open pollinated varieties of agricultural crops.
The Company has its seed processing plants located in Gujarat, where the seeds are processed, stored and packed with the help of modern machineries.

About Shanti Overseas (India) Ltd

Shanti Overseas (India) Limited was originally formed and registered as a partnership firm with the name of 'M/s Shanti Overseas' on 15 November 2004.
Thereafter 'M/s Shanti Overseas' was converted from a partnership firm to a Private Company with the name of 'Shanti Overseas (India) Private Limited' on April 18, 2011.
Subsequently, the Company was converted into a Public Limited Company and the name was changed to 'Shanti Overseas (India) Limited' on 20 January 2017. Shanti Overseas was formed for carrying out the trading business of agri-commodities.
Presently, it is engaged in manufacturing of soya products which includes, soya de-oiled cakes (soya meal), soya crude oil, degummed oil and soya lecithin, and is also involved in primary processing and trading of agri commodities such as chickpeas, soyabeans, cracked corn, maize, yellow peas, pulses etc.

FAQs for the comparison of Indo US Bio-Tech Ltd and Shanti Overseas (India) Ltd

Which company has a larger market capitalization, Indo US Bio-Tech Ltd or Shanti Overseas (India) Ltd?

Market cap of Indo US Bio-Tech Ltd is 161 Cr while Market cap of Shanti Overseas (India) Ltd is 6 Cr

What are the key factors driving the stock performance of Indo US Bio-Tech Ltd and Shanti Overseas (India) Ltd?

The stock performance of Indo US Bio-Tech Ltd and Shanti Overseas (India) Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Indo US Bio-Tech Ltd and Shanti Overseas (India) Ltd?

As of September 26, 2026, the Indo US Bio-Tech Ltd stock price is INR ₹80.5. On the other hand, Shanti Overseas (India) Ltd stock price is INR ₹5.68.

How do dividend payouts of Indo US Bio-Tech Ltd and Shanti Overseas (India) Ltd compare?

To compare the dividend payouts of Indo US Bio-Tech Ltd and Shanti Overseas (India) Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.